Evidence map›Paper›PMID 35855837›Full record

ArticleComputational and mathematical methods in medicine2022

Expression of DNA Helicase Genes Was Correlated with Homologous Recombination Deficiency in Breast Cancer.

Mengping Long, Hongjun Liu, Jinbo Wu, Shu Wang, Xin Liao, Yiqiang Liu, Taobo Hu

Open access · hybridAbstract read
In one paragraph

Article in Computational and mathematical methods in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. International journal of molecular sciences · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Mengping Long *Department of Pathology, Peking University Cancer Hospital, Beijing, China.ORCID https://orcid.org/0000-0002-8800-1897
Hongjun Liu *Department of Breast Surgery, Peking University People's Hospital, Beijing, China.
Jinbo WuDepartment of Breast Surgery, Peking University People's Hospital, Beijing, China.
Shu WangDepartment of Breast Surgery, Peking University People's Hospital, Beijing, China.ORCID https://orcid.org/0000-0002-8651-4795
Xin LiaoDepartment of Breast Surgery, Peking University People's Hospital, Beijing, China.ORCID https://orcid.org/0000-0002-7605-5708
Yiqiang LiuDepartment of Pathology, Peking University Cancer Hospital, Beijing, China.ORCID https://orcid.org/0000-0002-7239-2360
Taobo HuDepartment of Breast Surgery, Peking University People's Hospital, Beijing, China.ORCID https://orcid.org/0000-0001-5124-7167
Peking University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Homologous recombination deficiency which is currently measured by the homologous recombination deficiency (HRD) score including score of telomeric allelic imbalance (TAI), large-scale transition (LST), and loss of heterozygosity (LOH) is highly related with sensitivity to platinum-containing drug and PARP inhibitors. DNA helicases are essential components for the homologous recombination repair process in which DNA helicases unwind double-strand DNA utilizing ATP hydrolysis. In our study, the correlation between the expression of DNA helicase genes and HRD score in breast cancer was analyzed. The overexpression in half of the DNA helicase genes was found to be highly correlated with a high HRD score both in BRCA-mutated and BRCA wild-type breast cancer. Moreover, HRD score can be predicted by a linear function contributed by five DNA helicase genes. In conclusion, our study revealed a close relation between the overexpression of certain DNA helicase genes and the deficiency of homologous recombination repair in breast cancer.

Indexed as

Breast NeoplasmsDNA HelicasesFemaleHomologous RecombinationHumansLoss of HeterozygosityPoly(ADP-ribose) Polymerase InhibitorsDNA HelicasesPoly(ADP-ribose) Polymerase Inhibitors

Identifiers

PMID35855837
PMCPMC9288330
OpenAlexW4284958388

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.